Moving ahead: Identifying current deal drivers and trends affecting collaborations.- Analyzing how recent Supreme Court decisions change the playing field for companies engaged in licensing deals.
- Choosing the right partner and deal structure to maximize value and the future success of the deal.
- Selecting the most viable and profitable compensation structure.
- Minimizing risks through effective due diligence.
- Leveraging and safeguarding IP rights during negotiations.
- Alliance management: Establishing governance structures, diligence assurances and litigation management for a successful collaboration.
- Successfully negotiating collaborative research agreements with academic institutions.
- Addressing the critical importance of termination provisions.
- Incorporating change in control provisions into the agreement in light of the recent surge of M&A activity.
- Making an early assessment of the impact of generics and regulatory matters on the collaboration.
- Coordinating U.S. and international business strategies.
An additional master class entitled: "The "Win-Win" Collaborative Agreement: Ethical and Practical Negotiating and Drafting Strategies" will be offered on November 15, 2007. The master class will provide practical and detailed instructions on how to negotiate and draft effective and ethical collaborative agreements.
The agenda for the Pharma and Biotech Collaborative Agreements conference can be found here. A complete brochure for this conference, including an agenda, list of speakers, and registration form can be downloaded here.
The registration fee ranges from $1,995 (conference alone) to $2,595 (conference and master class). Those registering on or before September 15, 2007 will receive a $200 discount off the registration fee. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Patent Docs is a media sponsor of ACI's Pharma and Biotech Collaborative Agreements conference.
Comments